drugset / Trial / NCT00538343

RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases

NCT00538343

Phase 2 Terminated 14 enrolled Biogen
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether RTA 744 is effective in the treatment of breast cancer that has metastasized to the brain.

Timeline

Start
2007-10-31
Primary completion
2008-12-01
Completion
2009-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Berubicin Small molecule